Drug Intelligence Bulletin by Keith Graves

Graves and Associates Mar 7, 2023

The Illicit Use of Vyvanse: A Guide For Law Enforcement

What is Vyvanse? Vyvanse, also known by its generic name lisdexamfetamine, is a prescription-only stimulant used to…

Read article →
Graves and Associates Mar 3, 2023

Motorcycle Gangs and Afghan Methamphetamine: A Growing Threat to Australia

The Australian Federal Police (AFP) has launched an investigation targeting outlaw motorcycle gangs (OMGs) involved in a…

Read article →
Graves and Associates Feb 7, 2023

BC’s Drug Decriminalization: A Step in the Wrong Direction

The recent move by the government of British Columbia to decriminalize heroin, fentanyl, cocaine, and other hard drugs…

Read article →
Graves and Associates Feb 6, 2023

A New Name for a New Era: Rethinking the “War on Drugs”

The phrase “the war on drugs” has been widely used to describe the efforts of various governments and organizations to…

Read article →
Graves and Associates Jan 26, 2023

N-Desethyl Isotonitazene: A Potent Synthetic Opioid on the Rise

20x More Potent than Fentanyl: N-Desethyl Isotonitazene The opioid crisis in the United States continues to evolve as…

Read article →
Graves and Associates Jan 24, 2023

Surge in Fentanyl Deaths among Children under 14

A new report from Families Against Fentanyl, a nonprofit organization that raises awareness about the opioid, shows that…

Read article →
Graves and Associates Jan 6, 2023

Children Who OD on Cannabis Edibles Jumps 1,375%

A new analysis of records from the National Poison Data System published in Pediatrics this week published by Tweet,…

Read article →
Graves and Associates Jan 6, 2023

Metonitazine, the Fentanyl Like Drug, Found in Australia

Authorities in Australia have issued a public health alert after a synthetic opioid linked to a number of overdose…

Read article →